Search

Your search keyword '"Chalmers,James D"' showing total 106 results

Search Constraints

Start Over You searched for: Author "Chalmers,James D" Remove constraint Author: "Chalmers,James D" Publisher elsevier bv Remove constraint Publisher: elsevier bv
106 results on '"Chalmers,James D"'

Search Results

1. Bronchiectasis and asthma: Data from the European Bronchiectasis Registry (EMBARC)

3. Residual Lung Abnormality Following COVID-19 Hospitalisation is Characterised by Epithelial Injury

5. A core outcome set for bronchiectasis in children and adolescents for use in clinical research: an international consensus study

6. Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study

10. Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study

11. Risk of SARS-CoV-2 Infection and Disease Severity Among People With Bronchiectasis

12. The Economic Burden of Bronchiectasis

13. Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)

15. Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study

16. Physical and Mental Health Effects of Long Covid in People with Diabetes 12 Months after Hospitalisation in the UK: A Prospective Cohort Study

17. Bronchiectasis in Europe: Data from the European Bronchiectasis Registry (EMBARC)

18. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

19. Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial

22. Neisseria species as pathobionts in bronchiectasis

23. Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission

25. Sputum Proteomics in Nontuberculous Mycobacterial Lung Disease

26. Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations

31. High Frequency of Allergic Bronchopulmonary Aspergillosis in Bronchiectasis-COPD Overlap

34. The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease

35. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study

36. Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study

39. Development of Drugs for Nontuberculous Mycobacterial Disease

40. The Protective Effect of SARS-CoV-2 Antibodies in Scottish Healthcare Workers

41. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease

42. International Perspective on the New 2019 American Thoracic Society/Infectious Diseases Society of America Community-Acquired Pneumonia Guideline

44. Increased Chitotriosidase Is Associated With Aspergillus and Frequent Exacerbations in South-East Asian Patients With Bronchiectasis

47. Neutrophil Extracellular Traps are Increased in Severe Bronchiectasis and Reduced by Long-Term Azithromycin Treatment

48. Evaluation of active neutrophil elastase in sputum of bronchiectasis and cystic fibrosis patients: A comparison among different techniques

50. Efficacy and safety of tobramycin inhalation powder in bronchiectasis patients with P. aeruginosa infection: Design of a dose-finding study (iBEST-1)

Catalog

Books, media, physical & digital resources